Últimos Artículos de Lancet Diabetes & Endocrinology
- [Comment] Thank you to The Lancet Diabetes & Endocrinology's statistical and peer reviewers in 2025
- [Comment] Prioritising nutrition alongside paediatric obesity management medications
- [Editorial] A new dawn for osteoporosis drug development
- [Correspondence] Country-level implementation of Europe's Safe Hearts Plan for cardiovascular health
- [Articles] 3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial
- [Comment] 3 months of romosozumab: a pragmatic clinical solution
- [Review] Menopausal hormone treatment and breast cancer
- [Comment] Gene-environment interactions underlying temporal trends in type 2 diabetes prevalence
- [Articles] Temporal changes and genetic susceptibility to type 2 diabetes (1984–2019; HUNT): a longitudinal, population-based study
- [Comment] Inclisiran for children: is it worth it?
- [Articles] Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial
- [Review] Clinical features, investigation, and management of Addison's disease
- [Articles] Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study
- [Comment] More liberal use of bilateral adrenalectomy for bilateral adrenal tumours with cortisol excess
- [Correspondence] Feasibility of general population screening for type 1 diabetes in the UK: the ELSA study
- [Corrections] Correction to Lancet Diabetes & Endocrinology 2026; 14: 105–08
- [In Focus] Integrating mental health and non-communicable disease care: from declarations to practice
- [Correspondence] GLP-1 receptor agonists for obesity: eligibility across 99 countries
- [Comment] Circadian and sleep medicine: challenges and future directions for metabolic and endocrine research
- [Editorial] Aligning diabetes surveillance with clinical reality